Correlation Between Moleculin Biotech and Adial Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Adial Pharmaceuticals, you can compare the effects of market volatilities on Moleculin Biotech and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Adial Pharmaceuticals.
Diversification Opportunities for Moleculin Biotech and Adial Pharmaceuticals
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Moleculin and Adial is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Adial Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Adial Pharmaceuticals go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Adial Pharmaceuticals
Given the investment horizon of 90 days Moleculin Biotech is expected to generate 1.26 times more return on investment than Adial Pharmaceuticals. However, Moleculin Biotech is 1.26 times more volatile than Adial Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Adial Pharmaceuticals is currently generating about -0.3 per unit of risk. If you would invest 177.00 in Moleculin Biotech on November 3, 2024 and sell it today you would lose (26.00) from holding Moleculin Biotech or give up 14.69% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Moleculin Biotech vs. Adial Pharmaceuticals
Performance |
| Timeline |
| Moleculin Biotech |
| Adial Pharmaceuticals |
Moleculin Biotech and Adial Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Adial Pharmaceuticals
The main advantage of trading using opposite Moleculin Biotech and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |